-
The FDA can approve over-the-counter naloxone nasal sprays and auto-injectors

Naloxone, packaged with instructions, is one of the products being given out by the Baltimore Harm Reduction Coalition outreach workers. Amy Davis | Baltimore Sun | Getty Images The Food and Drug Administration said Tuesday it could potentially approve over-the-counter nasal sprays and auto-injectors that prevent opioid overdoses, part of its effort to expand access…
-
The world inhabitants reaches eight billion folks with India anticipated to surpass China

Indian passengers stand and hang on to a train departing from a railway station on the outskirts of New Delhi. Money Sharma | AFP | Getty Images The world population hit 8 billion people on Tuesday and India is expected to overtake China as the most populous country next year, according to United Nations forecasts.…
-
Pfizer releases information displaying Omicron boosters are higher than outdated pictures

A health worker administers a dose of Pfizer’s Covid-19 vaccine to a man at the Sanford Civic Center. With the emergence of the Omicron Covid-19 variant in numerous countries including the United States, the US Centers for Disease Control (CDC) encouraged all vaccinated adults to get their Covid-19 booster shot. Paul Hennessy | flare |…
-
Krankenversicherungsbedingungen zu erfahren, wenn die offene Immatrikulation beginnt

Halfpoint-Bilder | Moment | Getty Images Es ist die Saison der offenen Einschreibung, die Zeit, in der sich jedes Jahr Millionen amerikanischer Arbeitnehmer und Rentner für einen neuen oder bestehenden Krankenversicherungsplan entscheiden müssen. Aber die Auswahl einer Krankenversicherung kann ein schwindelerregendes Unterfangen sein. Gesundheitspläne haben viele bewegliche Teile – die auf den ersten Blick vielleicht…
-
Moderna (MRNA) Q3 Outcomes 2022

Modern lowered its 2022 sales forecast for its Covid-19 vaccine on Thursday after it missed Wall Street expectations for the third quarter. Moderna lowered its guidance to $18 billion to $19 billion in revenue from its Covid vaccine this year, down from its previous guidance of $21 billion. This is due to supply chain constraints…
-
Beijing approving BioNTech Covid vaccine will increase our shares tied to China

Estee Lauder (EL) and other club holdings with significant exposure to the Chinese economy rallied on Friday after it was announced that BioNTech’s (BNTX) Covid vaccine will soon be available to foreigners living in China. We’re cautiously optimistic on vaccine development, adding to hopes that Beijing will soften its restrictive pandemic policies after years of…
-
Flu hospitalization price at highest in decade, youngsters and elders most in danger

According to the Centers for Disease Control and Prevention, the US is facing the highest flu hospitalization rates in more than a decade, with children and the elderly being most at risk. Flu and respiratory syncytial virus had declined during the Covid-19 pandemic due to mitigation measures such as masks and social distancing. But as…
-
The US on the crossroads of the Covid pandemic as omicron subvariants emerge

dr Anthony Fauci, White House Chief Medical Advisor and Director of NIAID, answers questions from Senator Rand Paul (R-KY) at a hearing of the Senate Committee on Health, Education, Labor and Pensions January 11, 2022 on Capitol Hill in Washington, DC Greg Nash | swimming pool | Getty Images White House Medical Advisor Dr. Anthony…
-
The magic mushroom compound psilocybin could assist deal with melancholy, a research has discovered

The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest study of its kind ever conducted. David Buzzard – media-centre.ca/Getty Images LONDON – The naturally occurring psychedelic compound psilocybin can significantly reduce the symptoms of depression, according to data from the largest study of its kind ever…
-
We’re impressed by well being insurer Humana’s stable quarter and rosy outlook for subsequent 12 months

Clubholding Humana (HUM) reported a mixed but solid third quarter ahead of the opening bell on Wednesday. The early optimism for 2023 also supported our bullish view on the health insurer’s stock. Revenue rose 9% year over year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings per share rose 42% to…